JP2024545144A5 - - Google Patents

Info

Publication number
JP2024545144A5
JP2024545144A5 JP2024534340A JP2024534340A JP2024545144A5 JP 2024545144 A5 JP2024545144 A5 JP 2024545144A5 JP 2024534340 A JP2024534340 A JP 2024534340A JP 2024534340 A JP2024534340 A JP 2024534340A JP 2024545144 A5 JP2024545144 A5 JP 2024545144A5
Authority
JP
Japan
Prior art keywords
sequence
tracrrna
seq
rna molecule
nucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024534340A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024545144A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/081019 external-priority patent/WO2023107946A2/en
Publication of JP2024545144A publication Critical patent/JP2024545144A/ja
Publication of JP2024545144A5 publication Critical patent/JP2024545144A5/ja
Pending legal-status Critical Current

Links

JP2024534340A 2021-12-07 2022-12-06 Omni-103 crisprヌクレアーゼ-rna複合体 Pending JP2024545144A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163286855P 2021-12-07 2021-12-07
US63/286,855 2021-12-07
PCT/US2022/081019 WO2023107946A2 (en) 2021-12-07 2022-12-06 Omni-103 crispr nuclease-rna complexes

Publications (2)

Publication Number Publication Date
JP2024545144A JP2024545144A (ja) 2024-12-05
JP2024545144A5 true JP2024545144A5 (enExample) 2025-12-15

Family

ID=86731282

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024534340A Pending JP2024545144A (ja) 2021-12-07 2022-12-06 Omni-103 crisprヌクレアーゼ-rna複合体

Country Status (9)

Country Link
US (1) US20250034596A1 (enExample)
EP (1) EP4444876A2 (enExample)
JP (1) JP2024545144A (enExample)
KR (1) KR20240135610A (enExample)
CN (2) CN116887854A (enExample)
AU (1) AU2022405520A1 (enExample)
CA (1) CA3240329A1 (enExample)
IL (1) IL313397A (enExample)
WO (1) WO2023107946A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024506608A (ja) 2021-02-08 2024-02-14 エメンドバイオ・インコーポレイテッド Omni-103 crisprヌクレアーゼ
US12091688B2 (en) 2021-02-08 2024-09-17 Emendobio Inc. OMNI-103 CRISPR nuclease
CN120837655A (zh) * 2025-09-24 2025-10-28 中国人民解放军军事科学院军事医学研究院 磷酸化抑制工具在制备预防和/或治疗三阴性乳腺癌的药物中的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020069029A1 (en) * 2018-09-26 2020-04-02 Emendobio Inc. Novel crispr nucleases
IL298577A (en) * 2020-05-27 2023-01-01 Emendobio Inc Biallelic silencing of sarm1

Similar Documents

Publication Publication Date Title
JP2024545144A5 (enExample)
JP4791043B2 (ja) 同一固体支持体上で、2以上のオリゴヌクレオチドをタンデムに合成するための方法および組成物
FI4118198T3 (fi) Rna-ohjattuja nukleaaseja ja niiden aktiivisia fragmentteja ja variantteja ja käyttömenetelmiä
US5503995A (en) Exchangeable template reaction
US6280977B1 (en) Method for generating transcriptionally active DNA fragments
JP2005500025A5 (enExample)
JP2005501557A5 (enExample)
WO2009113709A1 (ja) 粘着末端を有するdna断片の調製方法
CN106282173B (zh) 克隆转基因生物中外源基因整合位点处侧翼序列的方法
JP2024543963A5 (enExample)
CN113564197B (zh) 一种CRISPR/Cas9介导的植物多基因编辑载体的构建方法和应用
CN105602972B (zh) 基于CRISPR-Cas9体外改造腺病毒载体的方法
Wilson et al. Nucleotide sequence of the Leishmania donovani medRNA gene
JP2024532784A5 (enExample)
Aprilyanto et al. Development of CRISPR/Cas9 plasmid for multiple sites genome editing in oil palm (Elaeis guineensis Jacq.)
CN114293264A (zh) 酶法靶序列随机sgRNA文库的制备方法
JP2024521196A5 (enExample)
CN114277447A (zh) 靶序列随机sgRNA全覆盖组的制备方法
CN106801044B (zh) 一种环状转座子复合物及其应用
CN118308469A (zh) 具有polyA序列的核酸的合成方法
CN114592022A (zh) 一种基于dna模板的长链tna合成方法
Chutia et al. Recent developments in RACE-PCR for the full-length cDNA identification
US20250171820A1 (en) Method for producing oligonucleic acid
CN112176422A (zh) Rna文库的构建方法
CN110577972A (zh) CRISPR/Sa-ShaCas9基因编辑系统及其应用